Evidence map›Paper›PMID 31892804›Full record

ArticleAnnals of gastroenterology

Brain and bone marrow metastases from rectal cancer.

Konstantina Thomopoulou, Stavroula Manolakou, Ippokratis Messaritakis, Maria Tzardi, Eleni Lagoudaki, Anastasios Koutsopoulos, Andreas Koulouris, George Kanellis, Konstantinos Kalbakis, Dimitris Mavroudis and 1 more

Abstract readCase Reports
In one paragraph

Article in Annals of gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Konstantina ThomopoulouMedical Oncology Department, University Hospital of Heraklion, Crete (Konstantina Thomopoulou, Stavroula Manolakou, Andreas Koulouris, Konstantinos Kalbakis, Dimitris Mavroudis, Ioannis Souglakos).
Stavroula ManolakouMedical Oncology Department, University Hospital of Heraklion, Crete (Konstantina Thomopoulou, Stavroula Manolakou, Andreas Koulouris, Konstantinos Kalbakis, Dimitris Mavroudis, Ioannis Souglakos).
Ippokratis MessaritakisLaboratory of Translational Oncology, Faculty of Medicine, University of Crete (Ippokratis Messaritakis).
Maria TzardiDepartment of Pathology, University Hospital of Heraklion, Crete (Maria Tzardi, Eleni Lagoudaki, Anastasios Koutsopoulos).
Eleni LagoudakiDepartment of Pathology, University Hospital of Heraklion, Crete (Maria Tzardi, Eleni Lagoudaki, Anastasios Koutsopoulos).
Anastasios KoutsopoulosDepartment of Pathology, University Hospital of Heraklion, Crete (Maria Tzardi, Eleni Lagoudaki, Anastasios Koutsopoulos).
Andreas KoulourisMedical Oncology Department, University Hospital of Heraklion, Crete (Konstantina Thomopoulou, Stavroula Manolakou, Andreas Koulouris, Konstantinos Kalbakis, Dimitris Mavroudis, Ioannis Souglakos).
George KanellisHematopathology Department, Evangelismos Hospital, Athens (George Kanellis), Greece.
Konstantinos KalbakisMedical Oncology Department, University Hospital of Heraklion, Crete (Konstantina Thomopoulou, Stavroula Manolakou, Andreas Koulouris, Konstantinos Kalbakis, Dimitris Mavroudis, Ioannis Souglakos).
Dimitris MavroudisMedical Oncology Department, University Hospital of Heraklion, Crete (Konstantina Thomopoulou, Stavroula Manolakou, Andreas Koulouris, Konstantinos Kalbakis, Dimitris Mavroudis, Ioannis Souglakos).
Ioannis SouglakosMedical Oncology Department, University Hospital of Heraklion, Crete (Konstantina Thomopoulou, Stavroula Manolakou, Andreas Koulouris, Konstantinos Kalbakis, Dimitris Mavroudis, Ioannis Souglakos).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the development of new treatment options based on the molecular characterization of colorectal cancer, 20% of patients present de novo metastatic disease, whereas 30-40% of patients who receive curative treatment relapse during follow up. Herein, we report 2 cases with rectal cancer that developed uncommon sites of metastasis; the first patient had an isolated breast metastasis, while the second patient developed bone marrow infiltration with synchronous brain metastases. In order to evaluate the uncommon metastatic pattern of rectal cancer, we detected and enumerated circulating tumor cells (CTCs) using both immunofluorescence and real-time reverse transcriptase polymerase chain reaction in these patients' peripheral blood. The procedure revealed the presence of CTCs, positive for CEACAM5 but negative for epithelial phenotype (EpCAM-), that might explain the patients' metastatic potential and survival.

Indexed as

circulating tumor cellsrare metastasesRectal cancer

Identifiers

PMID31892804
PMCPMC6928473

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.